Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2003
03/06/2003WO2002044378A3 Wnt signalling assay, methods and uses thereof
03/06/2003WO2002043661B1 Recombinant anti-cd30 antibodies and uses thereof
03/06/2003WO2002042464A3 Human v2 vomeronasal receptor
03/06/2003WO2002034917A3 Secreted alpha-helical cytokine-like protein zlmda24
03/06/2003WO2002033083A3 Methods of using a human il-17-related polypeptide to treat disease
03/06/2003WO2002031151A3 Lipocalins
03/06/2003WO2002031147A3 Human transporter proteins and polynucleotides encoding the same
03/06/2003WO2002030982A3 Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use
03/06/2003WO2002028481A3 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
03/06/2003WO2002026947A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/06/2003WO2002024956A8 Genetic markers for tumors
03/06/2003WO2002022826A3 Methods and compositions for the construction and use of fusion libraries
03/06/2003WO2002022801A3 Mammalian receptor genes and uses
03/06/2003WO2002022678A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/06/2003WO2002022080A9 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
03/06/2003WO2002020765A3 38646, a guanine nucleotide exchange factor and uses therefor
03/06/2003WO2002020748A2 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof
03/06/2003WO2002020735A3 Enzymes having high temperature polymerase activity and methods of use thereof
03/06/2003WO2002018636A3 Improvements in and relating to marking using dna
03/06/2003WO2002016421A3 Altered ospa of borrelia burgdorferi
03/06/2003WO2002015701A3 Bacillus thuringiensis crystal protein hybrids
03/06/2003WO2002014500A3 Human genes and gene expression products
03/06/2003WO2002014498A3 Human voltage-gated sodium channel proteins (scn1a) and polynucleotides encoding the same
03/06/2003WO2002014492A3 Fatty liver disease resistant bovines
03/06/2003WO2002012987A3 Systems and methods for authenticating a user to a web server
03/06/2003WO2002012325A3 Suppressor gene
03/06/2003WO2002012281A9 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
03/06/2003WO2002010401A3 18431 and 32374, human protein kinase family members and uses therefor
03/06/2003WO2002007675A3 Omega-conopeptides
03/06/2003WO2002006501A3 Method for altering degradation of engineered protein in plant cells
03/06/2003WO2002006478A8 Extracellular matrix protein
03/06/2003WO2002002602A9 Slgp protein and nucleic acid molecules and uses therefor
03/06/2003WO2002000914A9 Bioengineered vehicles for targeted nucleic acid delivery
03/06/2003WO2001098361A9 Agonist anti-trk-c monoclonal antibodies
03/06/2003WO2001098343A9 Conserved diaphanous-related formin autoregulatory domain (dad)
03/06/2003WO2001096378A3 Human epithin-like serine protease
03/06/2003WO2001092525A8 Compositions and methods for the therapy and diagnosis of lung cancer
03/06/2003WO2001092304A3 Transporters and ion channels
03/06/2003WO2001090313A9 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS
03/06/2003WO2001086293A8 A method for designing and screening random libraries of compounds
03/06/2003WO2001083825A3 Colloid compositions for solid phase biomolecular analytical systems
03/06/2003WO2001075105A9 Human leucine-rich repeat family member and uses thereof
03/06/2003WO2001074900A9 Nuclear factor kb inducing factor
03/06/2003WO2001072781A9 Human genes and expression products
03/06/2003WO2001066741A9 Kcnb: a novel potassium channel protein
03/06/2003WO2001062924A9 Human g protein-coupled receptors
03/06/2003WO2001055393A9 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
03/06/2003WO2001038488A3 Gene expression by positive feedback activation of a cell type-specific promoter
03/06/2003US20030046733 Transformation of soybeans
03/06/2003US20030046732 Methods for regulating plant GABA production
03/06/2003US20030046731 Promoters which permit a caryopsis-specific expression or suppression of genes in genetically modified plants
03/06/2003US20030046730 Starch branching enzyme II of potato
03/06/2003US20030046729 Isolated nucleic acid molecules encoding Na+/H+ exchanger polypeptides for extrusion of monovalent cations, most preferably sodium ions from the cytosol of cells to provide the cell with increased salt tolerance
03/06/2003US20030046728 Compositions isolated from plant cells and their use in the modification of plant cell signaling
03/06/2003US20030046727 Arcelin-5 promoter and uses thereof
03/06/2003US20030046726 Encode for insecticidal polypeptides, particularly insecticidal proteins from Bacillus thuringiensis
03/06/2003US20030046725 Method of isolation of an organelle carrying a gene for a desired trait; physically inserting transgene-carrying organelle from donor into recipient
03/06/2003US20030046724 Crossing recipient parent with donor parent to produce F1 hybrid plant, transforming cell of F1 hybrid plant with transferred DNA, finding transformed F1 hybrid cell containing transferred DNA, using flanking DNA to identify parent
03/06/2003US20030046723 Recombinant polynucleotides and methods for altering the regulation of gene expression in plants are provided to modify plant's traits, in particular disease tolerance
03/06/2003US20030046722 Allowing the donor chromosomes or donor cells to be reprogrammed prior to insertion into an enucleated oocyte; also allows insertion of chromosomes or nuclei into recipient cells
03/06/2003US20030046721 HSPC150-like gene disruptions, compositions and methods related thereto
03/06/2003US20030046720 USP3-like deubiquitinating enzyme gene disruptions, compositions and methods related thereto
03/06/2003US20030046719 Transgenic mice comprising mutations in a proliferator-activated receptor gene; methods for identifying agents that modulate proliferator-activated receptor expression and function, and potential treatments for disease
03/06/2003US20030046718 Administering compounds having an effect on cardiac fibrosis, myocardial infarction, defects in electrical conductance, atherosclerosis, unstable plaque, and stroke in an animal which does not express an active SR-BI, and an apolipoprotein
03/06/2003US20030046717 Isolated nucleic acid that encodes a Patched like transmembrane protein, functioning in male germ cell development, and as a potential tumor suppressor
03/06/2003US20030046716 Providing transgenic mammal whose somatic and germ cells comprise nucleic acid sequence encoding PDGF operably linked to promoter which directs expression into mammary gland epithelial cells and obtaining milk from animal
03/06/2003US20030046715 H2-O modified transgenic animals
03/06/2003US20030045830 Inhibiting the expression of a specific gene involved in eye function by inducing or reverting a mutation in that gene by topically applying or injecting the chimeric oligonucleotide
03/06/2003US20030045746 Phosphorous organic compounds and their use
03/06/2003US20030045711 Epothilone derivatives and methods for making and using the same
03/06/2003US20030045704 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030045703 Novel forms of T cell costimulatory molecules and uses therefor
03/06/2003US20030045701 Polynucleotide constructs and methods of expression in a host cell
03/06/2003US20030045700 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045697 Regulatable growth of filamentous fungi
03/06/2003US20030045695 Ribozyme for detecting gene sequence
03/06/2003US20030045691 Reshaped human anti-hm 1.24 antibody
03/06/2003US20030045688 Human interleukin-four induced protein
03/06/2003US20030045686 Mutein polypeptide for use in the treatment of hypoxia and ischemic related tissue damages
03/06/2003US20030045683 H14 DNA and polypeptides
03/06/2003US20030045682 Antibodies immunospecific for STEAP1
03/06/2003US20030045498 Contacting the ocular cell with an expression vector comprising the nucleic acid sequence encoding the inhibitor of angiogenesis and the nucleic acid sequence encoding the neurotrophic agent.
03/06/2003US20030045497 Nucleotide sequence wherein one or two cytosines in at least one CpG motif has been replaced with a cytosine analogue resistant to methylation.
03/06/2003US20030045495 Method for selective expression of therapeutic genes by hyperthermia
03/06/2003US20030045494 Synthetic oligonucleotides complementary to nucleic acids encoding epidermal growth factor
03/06/2003US20030045493 Oligonucleotide compositions and their use to induce differentiation of cells
03/06/2003US20030045490 Therapeutic antisense phosphodiesterase inhibitors
03/06/2003US20030045488 Antisense oligonucleotides comprising universal and/or degenerate bases
03/06/2003US20030045487 Compound 8 to 50 nucleobases in length targeted to a 5' UTR, coding, 3' UTR or intron region of a nucleic acid molecule encoding Phospholipase A2, group IIA (synovial); specifically hybridizes with and inhibits expression
03/06/2003US20030045486 Amino-modified ribozymes
03/06/2003US20030045485 Reducing the viability of a proliferating mammalian cells such as cancer cells by increasing the level or activity of p53 in the cell.
03/06/2003US20030045470 Methods and compositions for modulating gluconeogenesis using PGC-1
03/06/2003US20030045466 Calcium binding protein
03/06/2003US20030045465 RTransport polymer comprising a linear or branched peptide having 10-300 amino acid residues, having from about 5 to 100% histidine residues; drug delivery, especially gene therapy and cancer chemotherapy
03/06/2003US20030045463 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045459 67 Human secreted proteins
03/06/2003US20030045438 Proteases from gram positive organisms
03/06/2003US20030044985 Electroporation system and method for facilitating entry of molecules into cells
03/06/2003US20030044983 Nucleic acid transfer complexes
03/06/2003US20030044982 Expression vector coding blood coagulation protein for use in the treatment of blood disorders
1 ... 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 ... 4023